Erectile Dysfunction, Parkinsons Disease
Conditions
Brief summary
Sildenafil (Viagra(R))is widely used by men with Parkinsons Disease (PD) and erectile dysfunction. A number of patients have reported that when they take Sildenafil, their need of anti-PD medication is reduced. We hypotheses that sildenafil increases brain blood flow and hence improves the function of specific brain regions, improving motor function. Motor function and cerebral blood flow of 8 patients will be tested before and after Sildenafil intake and before and after anti-PD medication.
Detailed description
Erectile dysfunction can be experienced by up tp 40% of men with Parkinsons Disease (PD). Sildenafil (Viagra(R))is widely used by men with PD and erectile dysfunction. A number of patients have reported that when they take Sildenafil, their need of anti-PD medication is reduced. We hypotheses that sildenafil increases cerebral blood flow in basal ganglia and hence improves the function, improving motor function. Motor function and cerebral blood flow (rCBF) of 8 patients will be tested before and after Sildenafil intake and before and after anti-PD medication. rCBF will be measured by the Xe133 inhalation method and a fast-rotating, brain-dedicated, single photon emission computerized tomograph (SPECT, Tomomatic, 232, Medimatic, Inc., Denmark). Two scans will be perfomed, when patients are i)in normal medicated state and ii) in normal medicated state 1 hour after intake of 100 mg sildenafil. Motor function will be measured i 4 conditions: i)in normal medicated state and ii) in normal medicated state 1 hour after intake of 100 mg sildenafil, iii) after 12 hours of discontiation of anti-PD mediciation and iiii) after 14 hours of discontiation of anti-PD mediciation and 1 hour after intake of 100 mg sildenafil.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Men * Parkinsons disease * Erectile dysfunction * previous tried sildenafil with beneficial effects on motor function
Exclusion criteria
* psychosis * Heart disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Motor function | 1 hour | Motor function assessed by Unified Parkinsons disease Rating Scale, section 3 before and after challenge with Sildenafil and before and after discontinuation of anti-PD medication for 12 hours. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cerebral Blood Flow (rCBF) | 1 hour | change in rCBF in basal ganglia from before to 1 hour after intake of 100 mg of sildenafil |
Countries
Denmark